← Leaderboards
Daniel Bloomfield
Columbia University Health Sciences
$1,256,312
Attributed
$1,256,312
Total exposure
6
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,256,312 · 6
By mechanism
M01$1,256,312 · 6
Top collaborators
No co-investigators on record.
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Richard P Sloan$20,573,768
- Daniel M Bloomfield$2,215,975
- Mathew S Maurer$11,052,259
- Michael R. Rosen$18,612,727
- Filippo Mancia$14,879,578
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchHuman SubjectHeart Disorder DiagnosisPostural HypotensionMyocardial Ischemia /HypoxiaMyocardium DisorderBiomarkerCardiovascular Disorder EpidemiologyDrug Screening /EvaluationCongestive Heart FailureHuman MortalityHuman Therapy EvaluationPrognosisQuality Of LifeElectrocardiographyEthanolaminesBaroreflexPostureVascular Smooth Muscle Nervous ControlBlood PressureEvaluation /TestingArrhythmiaAutonomic Nervous SystemAutonomic Reflex
Grant awards (14)
PREVALENCE AND PROGNOSTIC SIGNIFICANCE OF T WAVE ALTERNANS IN SEVERE CHF$192,910
M01 · FY2002 · RR
CLIN BENEFIT OF MIDODRINE HCL IN PATIENTS W/ NEUROGENIC ORTHOSTATIC H$192,910
M01 · FY2002 · RR
PREVALENCE AND PROGNOSTIC SIGNIFICANCE OF T WAVE ALTERNANS IN SEVERE CHF$192,910
M01 · FY2001 · RR
CLIN BENEFIT OF MIDODRINE HCL IN PATIENTS W/ NEUROGENIC ORTHOSTATIC H$192,910
M01 · FY2001 · RR
CLIN BENEFIT OF MIDODRINE HCL IN PATIENTS W/ NEUROGENIC ORTHOSTATIC H$0
M01 · FY2001 · RR
PREVALENCE AND PROGNOSTIC SIGNIFICANCE OF T WAVE ALTERNANS IN SEVERE CHF$0
M01 · FY2001 · RR
PROSPECTIVE MULTI CENTER STUDY TO COMPARE EFFECTIVENESS OF T WAVE ALTERNANS$121,168
M01 · FY2000 · RR
AUTONOMIC FUNCTION IN PATIENTS WITH SYNCOPE AND NORMAL SUBJECTS$121,168
M01 · FY2000 · RR
POSTPRANDIAL HYPOTENSION IN ELDERLY SUBJECTS DURING UPRIGHT TILT$121,168
M01 · FY2000 · RR
COMPAR TO MEAS BAROREFLEX SENSITIVITY IN NORMS DURING SUPINE &UPRIGH$121,168
M01 · FY2000 · RR
CLIN BENEFIT OF MIDODRINE HCL IN PATIENTS W/ NEUROGENIC ORTHOSTATIC H$0
M01 · FY2000 · RR
PREVALENCE AND PROGNOSTIC SIGNIFICANCE OF T WAVE ALTERNANS IN SEVERE CHF$0
M01 · FY2000 · RR
CLIN BENEFIT OF MIDODRINE HCL IN PATIENTS W/ NEUROGENIC ORTHOSTATIC H$0
M01 · FY2000 · RR
PREVALENCE AND PROGNOSTIC SIGNIFICANCE OF T WAVE ALTERNANS IN SEVERE CHF$0
M01 · FY2000 · RR